Lilly CEO Says AI Curing Cancer Within a Decade Is Unlikely
Eli Lilly CEO Dave Ricks described the vision of AI curing cancer within ten years as appealing but unlikely. [[fact-gbltxitt6]] Ricks said major gaps remain in human understanding of biology. [[fact-5tpghqs9h]] He said obtaining reliable evidence through randomized human trials remains a key bottleneck in determining R&D timelines. [[fact-lvbeo80m1]] The article states that finding drug candidates faster does not mean proving them safe and effective for patients can happen just as quickly. [[fact-9mh6z7dc2]] Dario Amodei previously said cancer, Alzheimer's disease, heart disease, and mental illness could become a thing of the past in less than ten years. [[fact-la0h3az9y]] Ricks expects AI's progress in the pharmaceutical industry to be steady and gradual. [[fact-9l4oh8x8q]]